{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/sickle-cell-disease/management/management-sickle-cell-crisis/","result":{"pageContext":{"chapter":{"id":"1da4d393-99a4-51c1-b354-f1742b9d8b1f","slug":"management-sickle-cell-crisis","fullItemName":"Scenario: Management - sickle cell crisis","depth":2,"htmlHeader":"<!-- begin field ab074a0e-b7a2-4879-9f0d-d66e57f53d3f --><h2>Scenario: Management - sickle cell crisis</h2><!-- end field ab074a0e-b7a2-4879-9f0d-d66e57f53d3f -->","summary":"Covers the management of a sickle cell crisis in primary care.","htmlStringContent":"<!-- begin item 1feb5cd4-5a4e-4353-b870-c190523f9ceb --><!-- begin field 363ea2a0-cc9e-4f43-a1e1-acbd00886134 --><p>From birth onwards.</p><!-- end field 363ea2a0-cc9e-4f43-a1e1-acbd00886134 --><!-- end item 1feb5cd4-5a4e-4353-b870-c190523f9ceb -->","topic":{"id":"eb346bd0-1df2-5db2-a583-a366e34cfc19","topicId":"cc107f5d-efe6-4625-840e-5c4d4656869b","topicName":"Sickle cell disease","slug":"sickle-cell-disease","lastRevised":"Last revised in November 2016","chapters":[{"id":"d2b6d668-4d29-5c50-b65d-7467cbcce2dd","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"47f9af8d-8bda-55a3-bf81-eb75a7c4f02a","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"4a0ece3e-fa44-5ecd-9f55-ac17384d960c","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"44a5b5f9-fc8e-5024-87e3-a7e42dca3dd9","slug":"changes","fullItemName":"Changes"},{"id":"48757ec5-731a-57fd-8e39-d2cdf918179a","slug":"update","fullItemName":"Update"}]},{"id":"53ae2089-f545-5b24-99c5-a9fc620ea575","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"ffff20e4-5bc5-5c3b-bb59-858dba2fcf8d","slug":"goals","fullItemName":"Goals"},{"id":"16f85d1d-aec7-5173-9e0b-7d9456bdf3a5","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"12a41d5f-f447-5a64-868a-7648c7de9355","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5de2a0f3-a77d-5244-a401-dbd2cbcfefb3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"fc893fb4-51ec-5705-8dff-c7fba1969646","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"cc1cc5c4-df13-5e74-bde0-9f625ec4d1cf","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"02e2bd4f-75cd-5b59-9a81-c06d3bcf4d2f","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2a8eb5f7-6691-505b-bd86-9620102057a3","slug":"definition","fullItemName":"Definition"},{"id":"b756c83a-dcc0-5792-b3f9-fa9416929ce3","slug":"prevalence","fullItemName":"Prevalence"},{"id":"488c0ab1-f1c0-5fbf-bd1e-e327181c2e1f","slug":"prognosis","fullItemName":"Prognosis"},{"id":"b62a5aae-0dc3-5ac0-a1b1-d3ca0a7969ac","slug":"complications","fullItemName":"Complications"}]},{"id":"9336c0e7-d5d3-5dd6-99fd-50610ced96e1","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"dd5a2bec-36ce-58c0-b0f1-4ec5d4d17c21","slug":"when-to-suspect-sickle-cell-disease","fullItemName":"When to suspect sickle cell disease"},{"id":"bdbf4e2a-7a0c-5a2e-8b9c-4a9c661409ef","slug":"diagnosis-of-sickle-cell-disease","fullItemName":"Diagnosis of sickle cell disease"},{"id":"68746f0d-607a-5db5-8949-a87a4ed29328","slug":"when-to-suspect-an-acute-sickle-cell-crisis","fullItemName":"When to suspect an acute sickle cell crisis"},{"id":"ed48dbda-a404-50cf-a290-86fafcdb9908","slug":"assessment-of-acute-crisis","fullItemName":"Assessment of acute crisis"}]},{"id":"221fb88b-b951-5835-b282-ed218b637ff0","fullItemName":"Management","slug":"management","subChapters":[{"id":"e76854fe-5d45-5d85-8591-5712daa7e4d9","slug":"screening","fullItemName":"Scenario: Screening"},{"id":"1da4d393-99a4-51c1-b354-f1742b9d8b1f","slug":"management-sickle-cell-crisis","fullItemName":"Scenario: Management - sickle cell crisis"},{"id":"2bf8553c-1641-5bdc-bbc3-2615ddc5b84c","slug":"management-chronic-complications","fullItemName":"Scenario: Management - chronic complications"},{"id":"4493185d-8907-5325-a195-a7cd7039bd68","slug":"prevention-of-complications","fullItemName":"Scenario: Prevention of complications"},{"id":"2aeac855-0e31-598c-804d-41c8d9bc643f","slug":"management-sickle-cell-trait","fullItemName":"Scenario: Management - sickle cell trait"},{"id":"5b85ac92-9286-564f-88fb-ec37a6f4102e","slug":"contraception","fullItemName":"Scenario: Contraception"}]},{"id":"a424bf70-c56c-54a4-a2e2-019ab7c27c69","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"515607d5-c2e2-5a4c-8d83-1bb5e320badf","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"2148be5b-6502-5e45-b86b-e552aa3226fd","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"acc3b704-7f3d-51ed-869e-38e0309c53e5","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"2a46384b-d43c-536a-9a17-4b8953d8457a","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"46873f42-ab32-5894-b2fe-429a4e62161b","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"1dd24310-b8ac-5381-b51a-ca1f6c178d72","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"7405fe0a-8432-5e64-9fe0-4d112fd89232","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"221fb88b-b951-5835-b282-ed218b637ff0","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"8e788869-4775-5c6f-9282-679f1d55ba07","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field bc94c157-aacc-4c08-93c6-c0e8f128aea3 --><h3>How should I manage a person having a sickle cell crisis?</h3><!-- end field bc94c157-aacc-4c08-93c6-c0e8f128aea3 -->","summary":null,"htmlStringContent":"<!-- begin item 43b1e7c5-68d0-41a2-bc83-95dab6f29d59 --><!-- begin field 4e063cc8-ba5a-461c-a656-eb36f72b0a88 --><ul><li><strong>Consider the need for admission.</strong><ul><li><strong>Admit all people with clinical features of a sickle cell crisis to hospital unless they are:</strong><ul><li>A well adult who only has mild or moderate pain and has a temperature of 38°C or less.</li><li>A well child who only has mild or moderate pain and does not have an increased temperature.</li></ul></li><li><strong>Consider admission if the person presents with a fever but is otherwise generally well.</strong><ul><li>Admission is not necessarily required if the source of infection is obvious (such as a viral illness) and can be managed in the community.</li></ul></li><li><strong>Have a low threshold for admission:</strong><ul><li>In a child.</li><li>If the person has a temperature over 38°C (as there is a risk of rapid deterioration).</li><li>If the person has chest symptoms (as acute chest syndrome may develop quickly). Make sure that the person with chest symptoms and/or their parents/carers understand the importance of seeking urgent medical advice if their clinical state deteriorates, especially if breathing becomes faster or more laboured.</li></ul></li><li><strong>Whenever possible, admit the person to the specialist centre that has their records.</strong></li></ul></li><li><strong>Manage all other people at home.</strong><ul><li>The person and/or their family/carers will often have received a personal management plan from secondary care with clear guidance on how to manage their pain, including information on the appropriate analgesics for the intensity of pain, and when to seek medical advice. This should also include advice to:<ul><li>Increase fluid intake, as dehydration will prolong a painful episode.</li><li>Avoid other factors that may trigger acute painful crisis, such as cold weather and excessive physical activity.</li><li>Use distraction techniques, such as games, computers, and television.</li></ul></li><li>If the person has no personal management plan for pain:<ul><li>Prescribe paracetamol and/or ibuprofen (avoid ibuprofen if the person has renal impairment or significant proteinuria). Add codeine phosphate if these are not effective. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a> and <a class=\"topic-reference external-reference\" href=\"/topics/nsaids-prescribing-issues/\">NSAIDs - prescribing issues</a> for prescribing information.</li><li>Arrange an urgent assessment in hospital if the pain is not controlled by these measures. Strong opiates are not recommended for the management of acute painful crises in primary care.</li></ul></li><li><strong>Advise the person and/or their parents/carer to seek urgent medical advice, or go straight to hospital, if they:</strong><ul><li>Become unwell or develop a fever with a temperature greater than 38°C (or any increased temperature in a child).</li><li>Develop chest symptoms, such as breathlessness.</li><li>Have severe vomiting or diarrhoea (due to the risk of dehydration).</li></ul></li></ul></li></ul><!-- end field 4e063cc8-ba5a-461c-a656-eb36f72b0a88 --><!-- end item 43b1e7c5-68d0-41a2-bc83-95dab6f29d59 -->","subChapters":[{"id":"be679d97-fe3c-5a01-8019-8a7ca6b51d66","slug":"basis-for-recommendation-076","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field f80f2b7d-2f8d-41fd-92cb-e9e8e18656c6 --><h4>Basis for recommendation</h4><!-- end field f80f2b7d-2f8d-41fd-92cb-e9e8e18656c6 -->","summary":null,"htmlStringContent":"<!-- begin item 076a7255-c004-43b3-9834-2373c2d43ce6 --><!-- begin field f9a26d52-f23c-4dbb-a97b-2edd3eccb9d0 --><p>These recommendations are largely based on expert opinion in the guidelines <em>Sickle cell disease in childhood: standards and guidelines for clinical care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">PHE, 2010</a>]<em> </em>and <em>Standards for the clinical care of adults with sickle cell disease in the UK </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">Sickle Cell Society, 2008</a>], and on the opinion of previous expert reviewers of this CKS topic. </p><h5>Admission to hospital</h5><ul><li>Expert opinion in guidelines is that [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">Sickle Cell Society, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">PHE, 2010</a>]:<ul><li>A sickle cell crisis is often life threatening, and hospital admission is mandatory unless symptoms are very mild.</li><li>Admission may be required for pain relief.</li></ul></li><li>The Joint Royal Colleges Ambulance Liaison Committee recommends that, where possible, the person should be admitted to a hospital that has their clinical records (so that an individualized treatment plan can be followed) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">Joint Royal Colleges Ambulance Liaison Committee, 2009</a>].</li></ul><h5>Importance of fluid intake</h5><ul><li>A Cochrane systematic review (search date to 24<sup>th</sup> September 2014) noted that a decrease in body fluids promotes and maintains the sickling process. Fluids are therefore given to halt the sickling process, which should reduce the amount and duration of pain. No trials were found on the best way to replace fluids, which types of fluids to use, or the amount to give [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">Okomo and Meremikwu, 2015</a>].</li></ul><h5>Managing mild to moderate pain</h5><ul><li>These recommendations are based on expert opinion in the guidelines <em>Sickle cell disease in childhood: standards and guidelines for clinical care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">PHE, 2010</a>]<em> </em>and <em>Standards for the clinical care of adults with sickle cell disease in the UK </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">Sickle Cell Society, 2008</a>].</li><li>Expert opinion in the <em>S</em><em>tandards for the clinical care of adults with sickle cell disease in the UK </em>is that<em> </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">Sickle Cell Society, 2008</a>]:<ul><li>Pain should be managed according to the World Health Organisation (WHO) step ladder of non-opioid and opioid analgesia.</li><li>People with moderate pain should be managed with a combination of nonsteroidal anti-inflammatory drugs (NSAIDs) and weak opioids, provided there are no contraindications.</li><li>The use of non-pharmacological and psychological methods of pain management should be encouraged.</li></ul></li></ul><h5>Secondary care management</h5><ul><li>Early intervention with intravenous hydration (if the person cannot take adequate fluids), oxygen, blood transfusion, antibiotics, and physiotherapy can reduce morbidity and mortality [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">Sickle Cell Society, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">PHE, 2010</a>].</li><li>Other secondary care interventions include [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">Sickle Cell Society, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">PHE, 2010</a>]:<ul><li>The use of strong opiate analgesia to control pain.</li><li>Incentive spirometry every 2 hours for people with acute chest syndrome. This helps to prevent the complications (infiltrates and atelectasis) of acute chest syndrome developing in children and adults with chest and back pain.</li><li>Penile aspiration and irrigation with dilute epinephrine for men with acute priapism. This causes immediate detumescence (subsidence of erection) in most adolescent and men with acute priapism. Etilefrine is also effective. Surgery is necessary when medical treatment fails.</li></ul></li></ul><!-- end field f9a26d52-f23c-4dbb-a97b-2edd3eccb9d0 --><!-- end item 076a7255-c004-43b3-9834-2373c2d43ce6 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}